CSE: $HBOR OAKLAND, CA and TORONTO, Aug. 23, 2019

New Post Public Reply Private Reply Replies (0) Message Board
Lets Roll
155
CSE: $HBOR OAKLAND, CA and TORONTO, Aug. 23, 2019 /PRNewswire/ - Harborside Inc. ("Harborside" or the "Company" (CSE: HBOR), is pleased to announce that, subject to regulatory approval, it has retained Generation Advisors Inc. ("Generation" and Mackie Research Capital Corporation ("Mackie" to provide trading, market stabilization and liquidity services for the Company in accordance with regulatory guidelines. Generation and Mackie will trade the subordinate voting shares of Harborside (the "Shares" on the Canadian Securities Exchange (the "CSE" for the purposes of maintaining a reasonable market and improving the liquidity of the Shares.

Under the issuer trading services agreement between Generation and the Company (the "Generation Agreement" , the Company has agreed to pay Generation a fee of C$7,500, plus applicable taxes, per month, payable quarterly in advance. The initial term of the Generation Agreement will last for 180 days, and such term will be automatically renewed for a subsequent three month period unless terminated earlier by 30 days' prior written notice by the Company to Generation. Generation will also have the right to terminate the Generation Agreement at any time upon prior written notice to the Company.

Under the letter agreement between Mackie and the Company (the "Mackie Agreement" , the Company has agreed to pay Mackie an all-inclusive flat fee of C$5,000 per month, payable in advance. The engagement will be ongoing on a month-to-month basis and may be terminated by either party with written notice of 30 days. The Mackie Agreement is principally for the purposes of maintaining market stability and liquidity for the Shares and is not a formal market making agreement.

There are no performance factors contained in the Generation Agreement nor the Mackie Agreement. Neither Generation nor Mackie will receive any shares or options from the Company as compensation for services it will render.

About Harborside:

Harborside Inc. is one of the oldest, largest and most respected cannabis retailers in the world, operating two of the major dispensaries in the San Francisco Bay Area, two dispensaries in Oregon, and a cultivation facility in Salinas, California. Harborside has played an instrumental role in making cannabis safe and accessible to a broad and diverse community of California consumers. Co-founded by Steve DeAngelo and dress wedding in 2006, Harborside was awarded one of the first six medical cannabis licenses granted in the United States. Harborside is currently a publicly listed company on the CSE, trading under the ticker symbol "HBOR". Additional information regarding Harborside is available under Harborside's SEDAR profile at www.sedar.com, including in Harborside's Listing Statement dated May 30, 2019.

For the latest news, activities, and media coverage, please visit the Harborside corporate website at www.investharborside.com or connect with us on LinkedIn, Facebook, and Twitter.

The CSE has neither approved nor disapproved the contents of this news release. Neither the CSE nor its Market Regulator (as that term is defined in the policies of the CSE) accepts responsibility for the adequacy or accuracy of this release.

https://www.prnewswire.com/news-releases/harb...06391.html
Consider all my posts my opinion and not advice to buy or sell anything. I post on stocks I own or am considering owning. Do your own DD!
Scroll down for more posts ▼

Top 10 Most Recent News Articles

Top 5 Most Recently Viewed Articles

Concerns Rise Over Trump's Cryptocurrency Reserve Strategy

Updated Category News Views 192

Concerns About Cryptocurrency Announcements Prominent economist and market commentator Peter Schiff has urged a Congressional investigation into President Donald Trump's recent foray into cryptocurrency, suggesting that these announcements may involve insider trading and market manipulation. The Key Questions Raised In a recent post on X, Schiff sought answers to several...

Continue Reading
BriaCell Joins Prestigious Program to Boost Cancer Treatments

Updated Category News Views 145

BriaCell Enters MSK’s 2025 Therapeutics Accelerator Program BriaCell Therapeutics Corp. (Nasdaq: BCTX, BCTXW, BCTXZ, TSX: BCT) is thrilled to share the news of its selection into the Memorial Sloan Kettering Cancer Center (MSK) Therapeutics Accelerator Program for 2025. This prestigious program is designed to fast-track the clinical development of many innovative cancer...

Continue Reading
Exploring Current Net Asset Values of WisdomTree Funds

Updated Category News Views 114

Understanding Net Asset Value (NAV) in Investment Funds Net Asset Value (NAV) is a crucial metric for evaluating the performance of investment funds, representing the value of a fund's assets minus its liabilities. It's important for investors to keep track of NAV as it aids in making informed decisions regarding their investments. Here, we delve into the recent NAVs of...

Continue Reading
DoorDash's Innovative Tools Transforming Restaurant Dynamics

Updated Category News Views 208

Introduction to DoorDash's Expansion DoorDash (NASDAQ: DASH) has recently unveiled exciting developments regarding its Commerce Platform. This significant enhancement is set to assist restaurants in boosting direct sales while fostering better customer relationships across multiple channels. New Features for Restaurant Success The introduced tools are designed to uplift...

Continue Reading
Mezzion's Udenafil Shows Promise in ADPKD Study

Updated Category News Views 34

Positive News for Udenafil in Kidney Disease New updates from Mezzion Pharma Co., Ltd. have come across quite promising. They've reported some favorable results in a preclinical study of udenafil, targeting autosomal dominant polycystic kidney disease (ADPKD). It appears that this PDE5 inhibitor, typically used in aiding cardiovascular issues, now shows potential in...

Continue Reading